Skip to main content

Francesc Miro Mur

I am a researcher in the lab of "Systemic Autoimmune Diseases" of the VHIR. It is a recent operating team focused in the research of cellular and molecular mechanisms underlying the pathology of autoimmune diseases such as antiphospholipid syndrome. Previously, as an awarded Biomedical Researcher (PERIS-ICS) I studied the role of immune cells in modulating the inflammation during the acute phase of stroke.

Institutions of which they are part

Postdoctoral researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Francesc Miro Mur

Institutions of which they are part

Postdoctoral researcher
Systemic Diseases
Vall Hebron Institut de Recerca

I am a researcher in the lab of "Systemic Autoimmune Diseases" of the VHIR. It is a recent operating team focused in the research of cellular and molecular mechanisms underlying the pathology of autoimmune diseases such as antiphospholipid syndrome. Previously, as an awarded Biomedical Researcher (PERIS-ICS) I studied the role of immune cells in modulating the inflammation during the acute phase of stroke.

As a biochemist and cell biologist I started my career in basic research and sharing time as a biochemist lecturer at Universitat Autònoma de Barcelona. Regulation of cell function and activity by protein phosphorylation were the aims of my research. I moved to Paris to carry out my postdoctoral research career. My first postdoc was at CNRS-CEA to study the cell cycle progression and apoptosis under the control of p53 tumour suppressor.. In my second postdoc at Institut Curie I made a change starting a research career on immunology, looking into cellular and functional interaction between T lymphocytes and dendritic cells. It was during this amazing stage I collaborated with clinicians and saw the benefits of translational research. I spent two years at Cibbim working as a team leader in projects about molecular mechanisms of inflammation driving to senescence and about immunological basis of adverse reactions to bioimplants. At IRB I took the opportunity of doing a project in aminoacyl-tRNA synthetases as infectious agents in amebiasis, and also I turned to neuroimmunology and did research in brain ischemia.

1988-1993 BSc in Biology, speciality Biochemistry. UAB, Barcelona
1992-1993 Undergraduate collaborator, Biochem Dept, UAB
1995 Master Fellow, Laboratoire Cancerogénèse Moléculaire, CNRS-Villejuif, France
1996-1999 Ph.D., Biochem Dept, UAB
2000 Postdoc Researcher, Biochem Dept, Universita di Padova, Italy
2000-2003 Lecturer A3.6, Biochem & Mol Biol, UAB
2001-2003 Postdoc. Researcher, Lab Oncogénèse Moléculaire, CEA-CNRS, France
2003-2006 Postdoc Researcher, Cancer & Immunity Lab, Institut Curie, France
2007-2009 Postdoc Researcher, CIBER-nanomedicine, VHIR, Barcelona
2009-2011 Postdoc Researcher, Gene translation Lab, IRB-Barcelona
2011-2016 Postdoc Researcher, IDIBAPS, Barcelona
2017-2019 PERIS Researcher, Hospital Clinic, Barcelona

Projects

Ajuts Grups de Recerca (SGR) 2022

IP: Jaume Alijotas Reig
Collaborators: Moisés Labrador Horrillo, Carmen Pilar Simeón i Aznar, Anna Sala Cunill, Roser Solans Laque, Segundo Bujan Rivas, Mar Guilarte Clavero, Vicenç Fonollosa Pla, Fernando Martínez Valle, Victòria Cardona Dahl, Francesc Miro Mur, Alfredo Guillen Del Castillo, Albert Selva O'Callaghan, José Pardos Gea, Laura Donaire Lancharro, Ariadna Anunciacion Llunell
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00048
Duration: 01/01/2022 - 30/06/2025

Envejecimiento endotelial y procesos inflamatorios crónicos

IP: Francesc Miro Mur
Collaborators: -
Funding agency: Fundació de l'Agrupació Mútua
Funding: 15000
Reference: FAMV/01/2008
Duration: 01/01/2009 - 31/12/2009

Envejecimiento endotelial y sus efectos pleiotrópicos sobre procesos inflamatorios, de la respuesta inmune y angiogénesis

IP: Francesc Miro Mur
Collaborators: Jaume Alijotas Reig, Simon Schwartz Navarro
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 36000
Reference: FMMA/05/2008
Duration: 24/09/2008 - 23/09/2011

CIBER: Bioingenieria, biomateriales y nanomedicina

IP: -
Collaborators: Ibane Abasolo Olaortua, Manuel López Cano, Jaume Alijotas Reig, Francesc Miro Mur, Eloy Espín Basany, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua
Funding agency: CIBER Bioing., Biomateriales y Nanomedicina , BBN
Funding: 480000
Reference: CB06/01/0012
Duration: 01/01/2007 - 31/12/2010

Related news

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

It will allow the promotion of research on systemic autoimmune-based diseases that especially affect women of childbearing age and, therefore, can also appear during pregnancy.

Related professionals

Pablo Vilalta Gras

Pablo Vilalta Gras

Zelador/a
General Services and Infrastructures Unit
Manager
Read more
Carmen Sanchez Suarez

Carmen Sanchez Suarez

Molecular Medical Imaging
Read more
Laura Rubio Guerrero

Laura Rubio Guerrero

Medium Grade Technician
Purchase and Biddings Unit
Finance Directorate
Read more
Joana Ramis Garcia

Joana Ramis Garcia

Predoctoral researcher
Pharmacokinetic Nanoparticles
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.